Accordantly, Cai et al.44and Wei et al.45reported that SPINK13 could inhibit tumor growth and metastasis via urokinase‐type plasminogen activator in ovarian cancer and hepatocellular carcinoma. Here, SPINK13 is linked to ovarian carcinoma.